Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market
April 23, 2026
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH responsibilities. This session examines common gaps between clinical and commercial operations, inspection...